摩根士丹利:中国中药控股或受益于私有化进展

美港电讯
17 Sep 2024

【摩根士丹利:中国中药控股或受益于私有化进展】金十数据9月17日讯,摩根士丹利表示,鉴于投资者倾向于认为中国中药控股私有化提议将会实现,他们可能会以积极的态度解读该交易的月度更新。该交易两个先决条件的进展“是程序性的和微妙的”。中国中药控股股价今年已上涨11%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10